-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pharmaceutical Net, April 13th, a reporter learned from the Ministry of Finance on April 12 that the Ministry of Finance has recently issued an accounting information quality inspection announcement (No.
40) to address Changbaishan Pharmaceutical, Jiangsu Hengrui Pharmaceutical, Shandong Buchang Pharmaceutical, and Jiangsu Hausen.
19 pharmaceutical companies including Pharmaceutical and Shenzhen China Resources Sanjiu issued top-level administrative penalties in accordance with the relevant provisions of the current accounting law.
40) to address Changbaishan Pharmaceutical, Jiangsu Hengrui Pharmaceutical, Shandong Buchang Pharmaceutical, and Jiangsu Hausen.
19 pharmaceutical companies including Pharmaceutical and Shenzhen China Resources Sanjiu issued top-level administrative penalties in accordance with the relevant provisions of the current accounting law.
It is reported that in accordance with the "Accounting Law of the People's Republic of China", in response to the chronically high drug prices reported by the people, the Ministry of Finance, in conjunction with the National Medical Insurance Bureau, implemented accounting information quality inspections on 77 pharmaceutical companies in 2019.
The inspection focused on the cost structure of pharmaceutical products, found out the reasons for the falsely high prices of medicines, deterred the illegal behaviors of pharmaceutical companies such as selling gold and driving up the prices of medicines , and ensured the smooth progress of major reforms such as centralized drug pharmnet.
com.
cn/news/yyzb/" target="_blank">purchases .
The inspection focused on the cost structure of pharmaceutical products, found out the reasons for the falsely high prices of medicines, deterred the illegal behaviors of pharmaceutical companies such as selling gold and driving up the prices of medicines , and ensured the smooth progress of major reforms such as centralized drug pharmnet.
com.
cn/news/yyzb/" target="_blank">purchases .
According to the announcement, after investigation, some pharmaceutical companies have the following problems: one is the use of false invoices and bills to arbitrage funds for external use; the other is fictitious business matters or the use of pharmaceutical promotion companies to arbitrage funds; the third is other accounting calculations such as irregular setting of account books problem.
The above behavior violates Article 9 of the "Accounting Law of the People's Republic of China" and other provisions.
The above behavior violates Article 9 of the "Accounting Law of the People's Republic of China" and other provisions.
According to the announcement, the Ministry of Finance has imposed administrative penalties on 19 pharmaceutical companies inspected by the relevant supervision bureau of the Ministry of Finance in accordance with Article 42 of the "Accounting Law of the People's Republic of China.
" For other pharmaceutical companies, the Department of Finance (Bureau) responsible for the inspection shall impose administrative punishments on the spot.
Other violations of laws and regulations found during the inspection will be transferred to the competent authority for handling.
" For other pharmaceutical companies, the Department of Finance (Bureau) responsible for the inspection shall impose administrative punishments on the spot.
Other violations of laws and regulations found during the inspection will be transferred to the competent authority for handling.
The industry pointed out that the joint inspection by the Ministry of Finance and the National Medical Insurance Administration is an action to help medical reforms from the perspective of accounting information quality inspections, and to improve people’s satisfaction and sense of gain.
The inspections have played a deterrent effect on illegal behaviors by pharmaceutical companies and also Release the signal that will strengthen the supervision of finance and accounting.
The penalty amount is 30,000, ranging from 50,000 already existing accounting pharmnet.
com.
cn/" target="_blank">regulations laid down by the top grid penalties, accounting method currently under revision, expected after the implementation of the new accounting method, in accordance with zero tolerance, the principle of strict supervision, the standard punishment Will be greatly improved.
The inspections have played a deterrent effect on illegal behaviors by pharmaceutical companies and also Release the signal that will strengthen the supervision of finance and accounting.
The penalty amount is 30,000, ranging from 50,000 already existing accounting pharmnet.
com.
cn/" target="_blank">regulations laid down by the top grid penalties, accounting method currently under revision, expected after the implementation of the new accounting method, in accordance with zero tolerance, the principle of strict supervision, the standard punishment Will be greatly improved.
Pharmaceutical Net, April 13th, a reporter learned from the Ministry of Finance on April 12 that the Ministry of Finance has recently issued an accounting information quality inspection announcement (No.
40) to address Changbaishan Pharmaceutical, Jiangsu Hengrui Pharmaceutical, Shandong Buchang Pharmaceutical, and Jiangsu Hausen.
19 pharmaceutical companies including Pharmaceutical and Shenzhen China Resources Sanjiu issued top-level administrative penalties in accordance with the relevant provisions of the current accounting law.
40) to address Changbaishan Pharmaceutical, Jiangsu Hengrui Pharmaceutical, Shandong Buchang Pharmaceutical, and Jiangsu Hausen.
19 pharmaceutical companies including Pharmaceutical and Shenzhen China Resources Sanjiu issued top-level administrative penalties in accordance with the relevant provisions of the current accounting law.
It is reported that in accordance with the "Accounting Law of the People's Republic of China", in response to the chronically high drug prices reported by the people, the Ministry of Finance, in conjunction with the National Medical Insurance Bureau, implemented accounting information quality inspections on 77 pharmaceutical companies in 2019.
The inspection focused on the cost structure of pharmaceutical products, found out the reasons for the falsely high prices of medicines, deterred the illegal behaviors of pharmaceutical companies such as selling gold and driving up the prices of medicines , and ensured the smooth progress of major reforms such as centralized drug pharmnet.
com.
cn/news/yyzb/" target="_blank">purchases .
The inspection focused on the cost structure of pharmaceutical products, found out the reasons for the falsely high prices of medicines, deterred the illegal behaviors of pharmaceutical companies such as selling gold and driving up the prices of medicines , and ensured the smooth progress of major reforms such as centralized drug pharmnet.
com.
cn/news/yyzb/" target="_blank">purchases .
According to the announcement, after investigation, some pharmaceutical companies have the following problems: one is the use of false invoices and bills to arbitrage funds for external use; the other is fictitious business matters or the use of pharmaceutical promotion companies to arbitrage funds; the third is other accounting calculations such as irregular setting of account books problem.
The above behavior violates Article 9 of the "Accounting Law of the People's Republic of China" and other provisions.
The above behavior violates Article 9 of the "Accounting Law of the People's Republic of China" and other provisions.
According to the announcement, the Ministry of Finance has imposed administrative penalties on 19 pharmaceutical companies inspected by the relevant supervision bureau of the Ministry of Finance in accordance with Article 42 of the "Accounting Law of the People's Republic of China.
" For other pharmaceutical companies, the Department of Finance (Bureau) responsible for the inspection shall impose administrative punishments on the spot.
Other violations of laws and regulations found during the inspection will be transferred to the competent authority for handling.
" For other pharmaceutical companies, the Department of Finance (Bureau) responsible for the inspection shall impose administrative punishments on the spot.
Other violations of laws and regulations found during the inspection will be transferred to the competent authority for handling.
The industry pointed out that the joint inspection by the Ministry of Finance and the National Medical Insurance Administration is an action to help medical reforms from the perspective of accounting information quality inspections, and to improve people’s satisfaction and sense of gain.
The inspections have played a deterrent effect on illegal behaviors by pharmaceutical companies and also Release the signal that will strengthen the supervision of finance and accounting.
The penalty amount is 30,000, ranging from 50,000 already existing accounting pharmnet.
com.
cn/" target="_blank">regulations laid down by the top grid penalties, accounting method currently under revision, expected after the implementation of the new accounting method, in accordance with zero tolerance, the principle of strict supervision, the standard punishment Will be greatly improved.
The inspections have played a deterrent effect on illegal behaviors by pharmaceutical companies and also Release the signal that will strengthen the supervision of finance and accounting.
The penalty amount is 30,000, ranging from 50,000 already existing accounting pharmnet.
com.
cn/" target="_blank">regulations laid down by the top grid penalties, accounting method currently under revision, expected after the implementation of the new accounting method, in accordance with zero tolerance, the principle of strict supervision, the standard punishment Will be greatly improved.
Pharmaceutical Net, April 13th, a reporter learned from the Ministry of Finance on April 12 that the Ministry of Finance has recently issued an accounting information quality inspection announcement (No.
40) to address Changbaishan Pharmaceutical, Jiangsu Hengrui Pharmaceutical, Shandong Buchang Pharmaceutical, and Jiangsu Hausen.
19 pharmaceutical companies including Pharmaceutical and Shenzhen China Resources Sanjiu issued top-level administrative penalties in accordance with the relevant provisions of the current accounting law.
40) to address Changbaishan Pharmaceutical, Jiangsu Hengrui Pharmaceutical, Shandong Buchang Pharmaceutical, and Jiangsu Hausen.
19 pharmaceutical companies including Pharmaceutical and Shenzhen China Resources Sanjiu issued top-level administrative penalties in accordance with the relevant provisions of the current accounting law.
It is reported that in accordance with the "Accounting Law of the People's Republic of China", in response to the chronically high drug prices reported by the people, the Ministry of Finance, in conjunction with the National Medical Insurance Bureau, implemented accounting information quality inspections on 77 pharmaceutical companies in 2019.
The inspection focused on the cost structure of pharmaceutical products, found out the reasons for the falsely high prices of medicines, deterred the illegal behaviors of pharmaceutical companies such as selling gold and driving up the prices of medicines , and ensured the smooth progress of major reforms such as centralized drug pharmnet.
com.
cn/news/yyzb/" target="_blank">purchases .
Drug Drug Drugpharmnet. The inspection focused on the cost structure of pharmaceutical products, found out the reasons for the falsely high prices of medicines, deterred the illegal behaviors of pharmaceutical companies such as selling gold and driving up the prices of medicines , and ensured the smooth progress of major reforms such as centralized drug pharmnet.
com.
cn/news/yyzb/" target="_blank">purchases .
com.
cn/news/yyzb/" target="_blank"> Purchasepharmnet.
com.
cn/news/yyzb/" target="_blank"> Purchase Purchase
According to the announcement, after investigation, some pharmaceutical companies have the following problems: one is the use of false invoices and bills to arbitrage funds for external use; the other is fictitious business matters or the use of pharmaceutical promotion companies to arbitrage funds; the third is other accounting calculations such as irregular setting of account books problem.
The above behavior violates Article 9 of the "Accounting Law of the People's Republic of China" and other provisions.
Pharmaceutical companies Pharmaceutical pharmaceutical business enterprisesThe above behavior violates Article 9 of the "Accounting Law of the People's Republic of China" and other provisions.
According to the announcement, the Ministry of Finance has imposed administrative penalties on 19 pharmaceutical companies inspected by the relevant supervision bureau of the Ministry of Finance in accordance with Article 42 of the "Accounting Law of the People's Republic of China.
" For other pharmaceutical companies, the Department of Finance (Bureau) responsible for the inspection shall impose administrative punishments on the spot.
Other violations of laws and regulations found during the inspection will be transferred to the competent authority for handling.
" For other pharmaceutical companies, the Department of Finance (Bureau) responsible for the inspection shall impose administrative punishments on the spot.
Other violations of laws and regulations found during the inspection will be transferred to the competent authority for handling.
The industry pointed out that the joint inspection by the Ministry of Finance and the National Medical Insurance Administration is an action to help medical reforms from the perspective of accounting information quality inspections, and to improve people’s satisfaction and sense of gain.
The inspections have played a deterrent effect on illegal behaviors by pharmaceutical companies and also Release the signal that will strengthen the supervision of finance and accounting.
The penalty amount is 30,000, ranging from 50,000 already existing accounting pharmnet.
com.
cn/" target="_blank">regulations laid down by the top grid penalties, accounting method currently under revision, expected after the implementation of the new accounting method, in accordance with zero tolerance, the principle of strict supervision, the standard punishment Will be greatly improved.
pharmnet. The inspections have played a deterrent effect on illegal behaviors by pharmaceutical companies and also Release the signal that will strengthen the supervision of finance and accounting.
The penalty amount is 30,000, ranging from 50,000 already existing accounting pharmnet.
com.
cn/" target="_blank">regulations laid down by the top grid penalties, accounting method currently under revision, expected after the implementation of the new accounting method, in accordance with zero tolerance, the principle of strict supervision, the standard punishment Will be greatly improved.
com.
cn/" target="_blank">Regulationspharmnet.
com.
cn/" target="_blank"> and regulations
